RC

Raj Chhari

Active Director Additional Director DIN 10784798
DIN 10784798 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Sep 2024
Shareholding value •••• Premium profile

About Raj Chhari

Data last updated:

Raj Chhari is an Additional Director at Samasta Pharma Private Limited (since 2024), Director at Leadaspire Infrastructures Private Limited (since 2024) and Director at Euphoria Marketing Solutions Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Pharma, Real Estate and Construction and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹18.10 Cr; the largest is Samasta Pharma Private Limited at ₹17.59 Cr (FY 2022). Earlier, Raj Chhari was an Additional Director at Pulsenet Technologies Private Limited (2025).

DIN 10784798
Primary Designation Additional Director
Industry Pharma
First Appointment 23 Sep 2024
Oldest Company Age 6 yrs
Largest company Samasta Pharma Private Limited · ₹17.59 Cr (FY 2022)
Combined revenue ₹18.10 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Samasta Pharma Private Limited U51909MH2020PTC351301
Additional Director29 Oct 20242020₹17.59 Cr (FY 2022)Active
Director13 Dec 20242020₹38.6 Lakh (FY 2022)Active
Director07 Mar 20252022₹12.7 Lakh (FY 2024)Active
Skyalign Enterprises Private Limited U47710MH2024PTC433187
Director04 Oct 20242024Active
Zenithace Services Private Limited U70200MH2024PTC432513
Director23 Sep 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director03 Mar 20252023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Euphoria Marketing Solutions Private Limited
Leadaspire Infrastructures Private Limited
Samasta Pharma Private Limited
Skyalign Enterprises Private Limited
Premium access

Shareholding and investment profile for Raj Chhari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raj Chhari

Raj Chhari currently holds 5 directorships: Samasta Pharma Private Limited (Additional Director, since 29 Oct 2024, revenue ₹17.59 Cr (FY 2022)); Leadaspire Infrastructures Private Limited (Director, since 13 Dec 2024, revenue ₹38.6 Lakh (FY 2022)); Euphoria Marketing Solutions Private Limited (Director, since 07 Mar 2025, revenue ₹12.7 Lakh (FY 2024)); Skyalign Enterprises Private Limited (Director, since 04 Oct 2024); Zenithace Services Private Limited (Director, since 23 Sep 2024).

Raj Chhari was first appointed on 23 Sep 2024 as Director at Zenithace Services Private Limited. The most recent appointment on record is 07 Mar 2025 at Euphoria Marketing Solutions Private Limited.

The 3 current companies of Raj Chhari that report revenue have a combined latest revenue of ₹18.10 Cr: Samasta Pharma Private Limited ₹17.59 Cr (FY 2022); Leadaspire Infrastructures Private Limited ₹38.6 Lakh (FY 2022); Euphoria Marketing Solutions Private Limited ₹12.7 Lakh (FY 2024).

Raj Chhari held 1 earlier board appointment: Pulsenet Technologies Private Limited (Additional Director, 03 Mar 2025 to 13 Sep 2025).

The current boards of Raj Chhari's companies include Lavi Bhanu (Samasta Pharma Private Limited), Mohammed Saleem Shaikh (Leadaspire Infrastructures Private Limited), Vikash Kumar Chhari (Euphoria Marketing Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available